Rafferty Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-217,123
| Closed | -$369K | – | 1139 |
|
|
2022
Q2 | $369K | Sell |
217,123
-318,991
| -60% | -$542K | ﹤0.01% | 853 |
|
|
2022
Q1 | $1.1M | Sell |
536,114
-70,649
| -12% | -$145K | 0.01% | 757 |
|
|
2021
Q4 | $2.28M | Sell |
606,763
-134,152
| -18% | -$503K | 0.01% | 610 |
|
|
2021
Q3 | $3.83M | Sell |
740,915
-78,200
| -10% | -$404K | 0.03% | 377 |
|
|
2021
Q2 | $3.49M | Sell |
819,115
-213,246
| -21% | -$908K | 0.02% | 460 |
|
|
2021
Q1 | $5.48M | Buy |
1,032,361
+883,301
| +593% | +$4.69M | 0.04% | 266 |
|
|
2020
Q4 | $803K | Buy |
+149,060
| New | +$803K | 0.01% | 570 |
|